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ABSTRACT 
A surveillance and control program for the dairy cow disease 
Bovine 1eucosis is described. Efficiency, epidemiological, and 
cost minimization aspects are considered. Two statistical 
procedures found to be very useful are group testing and double 
sampling. Methods for estimating initial prevalence of the 
disease are discussed. The proposed program will not be prohibi-
tively costly and can result in new information on dairy cattle 
as well as giving a surveillance and control procedure for the 
disease. 
1.1 
1. INTRODUCTION 
Present action by European dairymen to create a Bov1ne leucos1s virus 
(BLV)-free zone in Western Europe restricts the sale of U.S. grown dairy 
cows in Europe to BLV-negative animals and provides the motivation to 
develop a surveillance and control program for the disease Bov1ne leucos1s, 
caused by the Bov1ne leucos1s virus (BLV). Standards for exporting cows 
are that the cow and the herd from which the cow comes must be free of BLV 
for 90 days prior to the sale. A closed herd which has been BLV-free for 
90 days is unlikely to contain animals which are infected and who would 
later come asymptomatic for the disease. New York State dairymen who are 
interested in exporting dairy cattle are very interested in BLV testing, in 
establishing BLV-free herds, and in the possibility of establish a BLV-free 
zone in New York State. 
In order to achieve these goals and be able to export cows continu-
ously through time, it is necessary to set up a surveillance and disease 
control program for all herds interested in maintaining a BLV-free herd. 
While the Europeans have establish a BLV-eradication program which relies 
on a slaughter endemity program, this approach would be prohibitively 
expensive in the U.S. Therefore, we propose a program of disease sur-
veillance and improved management techniques with selective culling of 
BLV-positive animals. The application of statistical group testing 
techniques and epidemiologic techniques will make this program both cost 
effective and feasible. Such a program is described in the following 
sections. The prevalence of BLV varies tremendously between herds with an 
average prevalence of 20-25% for a herd. The prevalence of BLV in a herd 
will determine the sampling and management procedure. Several procedures 
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will be presented. Discussion is centered on herds with greater than 20% 
BLV (high prevalence), between 5% and 20% (medium prevalence), and below 5% 
(low prevalence). This classification of percentages is disease and 
investigator dependent. Various sampling procedures are useful in consider-
ably decreasing laboratory costs. Two of these are group testing (see, 
e.g., Bush er a1., 1984; Dorfman, 1943; Hwang ec a1., 1981; Pfeiffer and 
Enis, 1978; Raghavarao and Federer, 1973; Sobel, 1967; Sobel and Groll, 
1959 and 1966) and double sampling (Neyman, 1938). Three forms of group 
testing are described. Several methods for obtaining preliminary estimates 
of prevalence are given. One method could lead to interesting new biolog-
ical knowledge. Criteria for pooling samples are discussed and critiqued. 
Various epidemiological aspects require consideration before a surveillance 
and control program should be instituted. These are briefly discussed. 
In light of the above a surveillance and control program for attaining 
a BLV-free status for a herd is described. Six aspects of surveillance and 
control programs are discussed: 
1. the determination of prevalence and incidence of BLV in herds. 
2. management and control programs for the prevalence level and 
conditions on a given dairy farm. 
3. the baseline epidemiologic survey for the initial determination 
of BLV prevalence. 
4. Application of group testing methods and procedures for process-
ing samples in a diagnostic laboratory. 
5. Determination of optimal sampling interval in the surveillance 
program. 
6. Cost minimization of the program. 
The initial disease prevalence and subsequent incidence and the time in 
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which a disease-free status is desired are important factors in determining 
sampling intervals and appropriate management techniques. Some variations 
of the control programs are described. Dissemination of results is an 
important factor in the success of the control program. Quality control 
procedures need to be instituted in all phases of the program in order to 
maintain high standards and quality of results. 
2.1 
2. SAMPLING PROCEDURES 
Once N samples are at the laboratory for diagnosis, various sampling 
procedures can be utilized to cut costs and/or the number of analyses. Two 
such procedures, group testing and double sampling, are discussed below. 
Three particular group testing procedures are described. There are many 
forms of group testing and double sampling but we describe only selected 
ones. 
Group testing procedure I: Dorfman (1943) describes the following proce-
dures for N samples where it is desired to determine which samples are 
positive or negative, diseased or not diseased, or any other binary 
classification. Let g be the number of samples pooled into one group. 
There will be G1 • N/g such pools or groups. Let p = the proportion 
diseased and q • 1-p = the proportion not diseased. 
If the pools have individuals randomly assigned, then the expansion of 
(p+q)g gives the proportion (frequency of occurrence) for 0,1,···,g 
diseased animals in a pool. 1-qg gives the expected proportion of disease-
free animals in a group of g. Hence, G2 a G1(1-qg) is the number of pools 
expected to be positive (contains a sample from a diseased animal). On 
these positive samples, analyses are conducted on each of the g samples in 
a pool. Therefore, the expected total number of analyses will be 
G + gG = ! + N(1-qg) = ~I! + 1 - qg) 1 2 g u\g (2.1) 
When 1/g • qg the number of analyses will be identical toN, i.e., the 
number required to analyze each sample separately. When 1/g • qg, this 
will be called the break-even group size. Also, the maximal value of p for 
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which groups testing can be used is determined as follows. The smallest 
group size greater than one is two. Therefore, 1/g = 1/2 must be greater t 
than qg = q 2 • That is, 1/2 > q!ax = • 7062 • This means that p < 1 -. 706 
= .294 results in savings from pooling. Then, pmax = 0.294 is maximum 
value for which group testing can be used in order to effect savings. 
The opc1maJ group s1ze given p is obtained as a solution for g to the 
equation 
g2 = (qg log 1/q) - 1 . 
opt (2.2) 
To illustrate the above, consider an example for N samples where p=.OS 
and q=.95. From equation (2.1) we obtain the following: 
Group size Number of analyses o1+gG2 
1 
2 
3 
4 
5 
6 
7 
8 
N 
N(1/2+1-.952 ) = 0.5975N 
N(1/3+1-.953 ) = 0.4760N 
N(1/4+1-.95~) = 0.4354N 
N(1/5+1-.955 ) = 0.4262N 
N(1/6+1-.956 ) = 0.4315N 
N(1/7+1-.957 ) G 0.4445N 
N(1/8+1-.99) = 0.4616N 
The optimal group size is g tmS and using this value results in a savings 
op 
of 1-.4262 • 57% over running individual analyses. Any of the group sizes 
of 3 to 8 result in over 52% savings. Figure 1 indicates the various 
values for p=.01 and .2. The savings (or loss) in efficiency for various g 
from 1 to 70 is given on the graph. 
For various p, g and the percent savings achieved are from (2.1) 
opt 
and (2.2): 
p q gopt % savings 
.01 .99 11 80 
.OS .95 5 57 
.10 .90 4 40 
.20 .80 3 18 
.25 .75 2 9 
.29 .71 2 0.4 
Figure 1. Amount of work for various group sizes 
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Group testing procedure II: This procedure involves continuous splitting 
of positive pools into two pools and testing the pools. It has been 
studied by a number of authors (e.g., Sobel, 1967, Sobel & Groll, 1959 and 
1966). For N samples the steps are 
Step 1 
Step 2 
Step 3 
Step 4 
Step 5 
Test a pool from all N samples. If negative stop and if positive 
go to step 2. 
Obtain two pools of size N/2 and test the two pools. 
Obtain two pools of size N/4 from each of the positive pools in 
step 2 and test. 
Obtain two pools of size N/8 from each of the positive pools in 
step 3 and test. 
Obtain two pools of size N/16 from each of the positive pools 
in step 4 and test. 
Proceed until the last split of positive pools results in analyses on 
individual samples. 
As an illustration of the above let N•72 samples: 
Step 1 
Step 2 
Step 3 
Step 4 
A pool from all 72 samples results in a positive result. 
Sample numbers 1-36 were put in one pool and 37-72 in a second 
pool. Suppose that both pools yields a positive result. 
Pools from samples 1-18, 19-36, 37-54, and 55-72 were obtained 
and pools 1-18 and 55-72 were positive. 
The two positive pools were split into four pools of 9 samples 
each, i.e., 1-9, 10-18, 55-63, 64-72; suppose all were positive 
except 55-63. 
Step 5 
Step 6 
Step 1 
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The three positive pools were split with six pools of size four 
or five, i.e, 1-4, 5-9, 10-13, 14-18, 64-67, and 68-72. Suppose 
that pools 1-4, 5-9, 10-13, 64-67, and 68-72 were positive. 
The five positive pools were split into pools of two or three, 
i.e., 1-2, 3-4, 5-6, 7-9, 10-11, 12-13, 64-65, 66-67, 68-69, and 
70-72. Suppose that pools 1-2, 7-9, 10-11, 64-65, and 70-72 were 
positive. 
Perform individual sample analyses on the positive pools in step 
6. 
The total number of analyses performed was 1 + 2 + 4 + 4 + 6 + 10 + 
(2+3+2+2+3) = 39. This resulted in a savings of 72 - 39 • 33 samples over 
doing the 72 samples individually. 
Group testing procedure III: Raghavarao and Federer (1973) and Bush et 
al. (1984) propose other methods of group testing. One such method is the 
following: 
Step 1 
Step 2 
Test pool from N samples. If positive, proceed. If not, stop 
and state all N samples are negative. 
Arrange N samples in as square an array as possible with r rows 
and c columns. Note that r+c is a minimum when r~c. Test the 
row pools and the column pools. In some cases the positive row 
and column pools uniquely determine the positive samples. When 
the positive or negative quality of a sample cannot be uniquely 
determined, proceed to Step 3. 
Step 3 
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For those rows and columns which are positive and for which the 
positive or negative value of a sample cannot be uniquely 
determined, these intersection samples are analyzed individually. 
Since p in these intersection samples may be fairly high, it may 
not be efficient to use group testing with groups of g=2, say. 
The above steps are illustrated with an example. Let N=72, r=8, and 
c=9. Suppose that samples 1, 2, 9, 11, 65, and 72 are positive but this is 
unknown. Since we know nothing about the samples we may as well array them 
as follows: 
Rows 1 2 3 4 
1 1 9 17 25 
2 2 10 18 26 
3 3 11 19 27 
4 4 12 20 28 
5 5 13 21 29 
6 6 14 22 30 
7 7 15 23 31 
8 8 16 24 32 
+ + + 
Columns 
5 
33 
34 
35 
36 
37 
38 
39 
40 
6 7 
41 49 
42 50 
43 51 
44 52 
45 53 
46 54 
47 55 
48 56 
8 9 
57 65 + 
58 66 + 
59 67 + 
60 68 
61 69 
62 70 
63 71 
64 72 + 
+ 
The row and column pools showing positive results are indicated above. We 
need to test samples 1, 2, 3, 8, 9, 10, 11, 16, 65, 66, 67, and 72. Thus 
with 8 + 9 = 17 analyses, the problem was reduced from 72 samples to 12 
samples. The total number of samples analyzed was 1 + 8 + 9 + 12 = 30 
instead of 72 to find the six positive samples 1, 2, 9, 11, 65, and 72. 
Obviously, as the number of positives increases the greater will be 
the number of analyses. The maximum number of analyses is 1 + r + c + N 
and the minimum number (all positives in the same row or column) is 
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1 + r + c. For example, suppose that there were eight positives. If these 
all fell in the same column, only 1 + 8 + 9 = 18 analyses would be re-
quired. If these eight fell in different rows and different columns, then 
1 + 8 + 9 + 64 analyses would be required. 
For each number of positives out of N all possible configurations need 
to be studied, their probabilities ascertained, and the relative efficien-
cies determined. For certain N, one could start with rc groups of size g 
and follow through as for single samples. Then, the positive or possibly 
positive groups would each be arrayed in a row-column array for individual 
samples and steps 2 and 3 will be repeated. The effect of r and c values 
for various numbers of defectives needs to be studied. 
Double sampling: Double sampling procedures, like group testing procedure 
I, have been in the literature and in use for many years. In the thirties, 
U.S.D.A. statisticians A. J. King and C. F. Sarle were using and discussing 
the following procedure. Variate x1 is cheap to obtain but is not what is 
desired. Variate x2 is expensive and desired. x1 and x2 are related. A 
large sample of x1 is obtained and a relatively small sample of both x1 and 
x2 is obtained. An illustration is for x1 to be a response to a question 
from a mailed interview and x2 to be the response from a personal inter-
view. The large sample for X1 is used to reduce the variance in x2 using 
regression analyses. The procedure was described in a publication by 
Neyman (1938). The above is one of many forms that double sampling can 
take. 
Double sampling involves the use of two or more procedures, assays, 
methods, etc., when the cost, efficiency, availability, and/or accuracy of 
the procedures differ. In disease studies, two methods of ascertaining the 
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presence or absence of a disease might be available. One could be a 
quick-and-dirty (not accurate) one and the second a complicated, precise, 
and expensive method. The latter might be used on pooled samples whereas 
the former might suffice on the individual samples. Or, one could use the 
procedure described for the original concept of double sampling in surveys. 
In disease studies, if the prevalence is high and a second sampling is 
anticipated, then the quick-and-dirty procedure might be used first. If 
the prevalence was low, the expensive-precise method might be used. 
Other examples could involve responses from milk samples XI and 
responses from blood samples x2• Milk samples are obtained more cheaply 
and easily than blood samples, especially if a veterinarian is required to 
obtain the blood samples. The number of skilled, reliable, and accurate 
technicians may be limited relative to the number of samples requiring 
processing. The use of unskilled technicians to obtain analyses, say XI' 
and of skilled technicians to obtain analyses, say x2 , would represent 
another example. Blood samples might be obtained by unskilled individuals 
to obtain response XI on a large sample and from a small sample by both the 
unskilled person and a trained veterinarian. 
3.1 
3. PRELIMINARY ESTIMATES OF PREVALENCE 
There are many procedures for obtaining a preliminary estimate of the 
prevalence of a disease in a herd or population of herds. Previous data 
are often a source for prevalence estimates. These data could come from 
previous studies, investigations, or surveys. In addition, some farmers 
often have an idea of the prevalence in their herds. A local veterinarian 
may be able to provide an estimate of prevalence in a region. State 
veterinarians may have data on prevalence in various regions of the state. 
In lieu of previous estimates of prevalence, an investigator may draw 
a small subsample of the samples obtained and estimate prevalence for the 
region or for a herd. This preliminary estimate could be used to determine 
group size for a group testing procedure or for determining whether or not 
to utilize a double sampling procedure. In a region this subsample may be 
a random sample of a fraction of a percent, say, whereas in a herd it could 
be ten samples. 
In certain instances, another procedure can be used to obtain a 
prevalence estimate in a given herd. To use this procedure, certain 
information must be available. The minimum information necessary is the 
number of cows in a herd N, the mean titer level for nondiseased cows ~f' 
and the mean titer level for diseased cows ~d· This is depicted in the top 
graph in Figure 2. In a pooled sample (equal amount from each of theN 
cows) the mean titer level would be determined and is equal to M, say. Now 
there are Nd diseased cows and Nf • N-Nd disease-free cows in the herd. Nd 
is unknown, and a solution needs to be found. Since 
(3.1) 
100 
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0 
1-lf 
100 
I 
frequency 
percent 
0 
Figure 2. Frequency distribution of mean titer level 
for disease-free and diseased cows. 
Mean titer level ~ 
1 I 
. 
mean titer level ~ 
3.3 
(3.2) 
A solution for prevalence is Nd/N • p. 
The above is the ideal situation which may never be achieved in 
practice. Instead, the situation in the bottom graph of Figure 2 may be 
more realistic because of variations in titer levels among cows and/or 
variation in estimating titer level in a given sample. Equation (3.2) can 
still be used to estimate Nd' say Nd, and the estimated prevalence would 
be p = Nd/N. A confidence limit for p can be obtained using first d 1 
and then d 2 in place of vd in (3.2). Since the interval [d1 ,d2 J contains 
5/6ths, say, of the distribution, this would be a 5/6ths = 83% confidence 
interval on p. 
It would be desirable to collect information on titer level among 
disease-free and among diseased cows for other diseases. This requires 
that the actual titer level be recorded and not just whether a cow is 
classified as diseased or not diseased. Given empirical frequency distribu-
tions of titer levels, it may be possible to determine a mathematical form 
for this distribution. From the analytic form of the distribution, 
confidence intervals of any width may be determined for Nd, and consequent-
ly for p. It would appear that biological theory for disease would be 
considerably enhanced through this information. For a known population 
mean titer level of diseased and disease-free cows, a prevalence estimate 
from the herd pooled sample can be obtained. Then, an optimal group size 
for group testing can be selected. 
4.1 
4. CRITERIA FOR POOLING SAMPLES 
Two main conditions must be present before samples can be pooled. The 
first one is the sensitivity of a test procedure. Sensitivity needs to be 
defined. In performing an assay, information is needed on the proportion 
of times the assay fails to detect the response when it is present. One 
would hope that this is zero but it must be ascertained and not assumed. 
Then sensitivity must be defined in terms of this actual proportion. 
Information is needed on various dilution rates of a sample. If the 
assay loses its sensitivity for dilutions less than 1/g, say, the group or 
pool size must be less than g. For BLV tests the work of Mammerickx et 
a1. (1984) is useful. They conclude that with the sensitivity for their 
ELISA (enzyme-linked immunosorbent assay), the group size g should be less 
than or equal to 75. Before any pooling procedure can be used with a given 
assay, it is necessary to determine the smallest dilution proportion for 
which the procedure remains sensitive. 
The second major condition that must be realized is that no antagon-
isms are set up when samples are pooled. If antibodies and/or antigens 
from different samples set up a reaction which lowers or raises the titer 
of a pooled sample, the results would probably not be usable. This would 
indicate that pooling procedures would not be useful for this particular 
study. Again a knowledge of antibody, antigen, and titer level inter-
actions would enhance the biological theory of disease. 
5.1 
5. EPIDEMIOLOGICAL ASPECTS 
In any disease program it is necessary to consider epidemiological 
aspects of the disease in the population. Some points for consideration 
are 
i) How should incidence and prevalence of a disease be measured? 
ii) How should measurements from a sample be made? 
iii) What specificities or peculiarities are associated with this 
disease? 
iv) Is the disease bacterial or viral? 
v) Is it necessary to use blood samples or can other samples (e.g., 
urine or milk) be used as effectively? 
vi) How is the disease transmitted? 
vii) How infectious is the disease? 
In measuring incidence and prevalence it is necessary to determine 
whether or not the herd or the individual animal should be the unit of 
consideration. The proportion of herds with one or more diseased animals 
may be the prevalence desired. For other situations, the proportion of 
diseased animals in a herd may be the desired statistic. 
6.1 
6. A PROPOSED SURVEILLANCE AND CONTROL PROGRAM 
The goal of any surveillance and control program for a disease such as 
BLV or other similar diseases should encompass the following: 
i) Determination of prevalence of disease in the population being 
studied - The population of dairy cows could be all the dairy 
cows in New York State or initially it could be cows in those 
herds where the owner has decided to cooperate in the program. 
For BLV, this could be the herds desiring to export dairy cows. 
This population must first be delineated and a sampling frame 
(list of herds) prepared. To determine prevalence in the 
population, a simple random sample or perhaps a stratified 
sampling plan such as proposed by Robson (1959) would suffice. 
ii) Determination of incidence of disease in the prescribed popula-
tion - Incidence is the rate of new infections occurring in the 
prescribed period of time. To obtain an estimate of incidence, 
it would be necessary to use a two-stage procedure such as the 
one described by Robson (1959). The rate of new infections 
would be desirable knowledge in setting up the control program. 
This would measure the effectiveness of the management program. 
The time interval between samplings would be related to the 
incidence rate. 
iii) Prevalence in a given herd - Since a control and surveillance 
program would need to be herd by herd, the prevalence of the 
disease in each herd in the target population needs to be 
ascertained to institute a control program. 
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iv) Control programs - A number of control programs could be 
instituted. For example, one control program, say A, could be 
to use a different or sterilized needle for each cow vaccinated 
or blood sample taken. Any other procedure that would infect a 
cow would be discontinued. A second control program, say B, 
would use A plus segregation of animals into two groups, i.e., 
disease and nondiseased. A separation of the two groups by as 
much as 60 feet would be sufficient for BLV. The diseased group 
would be milked last and contact with nondiseased animals 
eliminated. Any culling from the herd would be mostly from the 
diseased group. A third control program, say C, could be more 
drastic in that all animals found to be diseased would be 
eliminated immediately from the herd; control program A would 
also be in use. 
devised for BLV. 
Obviously, many other procedures could be 
Any control procedure selected would more than likely 
depend upon the prevalence p in a herd. For high values of p, 
say above 20%, control procedure A would probably be the only 
economically feasible program. It could be that program B would 
be used for these values of p but this would depend upon the 
facilities available on a given dairy farm. In some cases, 
division of the herd into two separate groups may be relatively 
inexpensive, whereas in other cases it could be expensive. For 
medium values of p, say from 5-20%, method B might be feasible. 
If p is less than 5%, the owner could opt for program C. In any 
event a number of management control programs would need to be 
described and presented to the owner, who would implement one or 
more of them. 
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v) Laboratory analyses - Routinely blood samples are taken from 
cows and sent to the New York State Diagnostic Laboratory for 
analysis to determine whether or not a cow has BLV. In order to 
make the processing of laboratory analyses feasible, and not 
inordinately expensive, it is suggested that one of the group 
testing procedures described in Section 3 be instituted. If it 
is fairly certain that one or more cows in a herd are diseased, 
step 1 should be skipped. In the first stages of the program, p 
could be relatively large, whereas p becomes much smaller as 
diseased BLV cows are culled from the herd. The efficiency of 
group testing increases as p decreases. Considerable savings 
can be effected when p becomes small, say one percent (see 
Figure 1) or less. The number of analyses required is reduced 
by 80% or more. Thus, the laboratory facilities may not need to 
be expanded to perform the desired analyses in a BLV surveil-
lance program. 
vi) Surveillance intervals The sampling intervals after institut-
ing control programs A, B, C, or some other one is dependent 
upon the incidence of BLV, the prevalence p in a herd, and the 
need for action. Since the incubation period is relatively 
long, say three to six months, for BLV, it is recommended that 
the first time interval for disease control program A be at 
one-year intervals and for B and C be three months. Here the 
reasoning is that the elimination of diseased animals will 
require a much longer time period for A than for B and C. Since 
p should be considerably reduced or even zero for the disease-
free group of the previous period, the second time interval 
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could be six months. The length of time between samplings 
should be doubled whenever a herd has been disease-free for the 
preceding two samplings. However, the interval should not be 
more than two or three years between samplings in a given herd. 
Since export standards require a herd to be BLV-free for 90 
days and for the animal to be BLV-free at the time of export, 
the above intervals may have to be changed to 90 days to conform 
to standards. Thus, when cows are being readied for sale, a 
sampling could be made and then another one 90 days later. This 
plus previous history on the BLV status of the herd should more 
than meet export standards. Any cow coming into a herd should 
meet the export standards also in order to avoid re-introducing 
BLV cows into a herd. The tests should be made on all young 
animals carried along with or introduced into the herd. 
7.1 
7. VARIATIONS OF CONTROL PROGRAMS 
In utilizing any control program such as A, B, or C of the previous 
section, it is necessary to ascertain the effectiveness of the program in 
reducing prevalence. A herd management program such as A may take several 
years to obtain a BLV-free herd. However, if infection is mainly trans-
mitted from cow to cow with a needle or from nursing a BLV dam, the culling 
of BLV animals and the use of good clean management procedures may dramati-
cally reduce incidence while the prevalence of BLV would be reduce through 
normal culling of cows. This would be a relatively cost effective method 
to attain BLV-free status for a herd. 
The separation of animals into BLV-free (at last test) and BLV-
positive groups could be expensive if the groups were of approximately the 
same size. If the BLV group was composed of a few animals, it may not be 
too difficult and expensive to maintain the two groups separately. As the 
culling of BLV cows continues, the second group becomes smaller and 
smaller. When p is low, program C may be the best program to follow. 
A disease such as BLV can be controlled by good management practices. 
Whenever other diseases can be likewise controlled, it may be advantageous 
to place any diseased animal in the second group and to cull them as 
expeditiously as possible. The BLV group may have cows with a variety of 
diseases. For some diseases, the isolation may have to be much more 
distant than that for BLV, which has been stated to be 60 feet or more. It 
may be that the diseased cows from several herds would be put into one 
designated and isolated herd until culled. 
8.1 
8. MINIMIZATION OF COSTS OF A CONTROL PROGRAM 
The costs in any control and surveillance program can become prohibi-
tive or very expensive at the least. It is necessary to study all aspects 
of the program and to minimize cost at every stage. The first costs to be 
considered are those to the farmer. A control and management program 
should be selected to meet the conditions on a particular farm. For 
example, if needles become too expensive for single use, some easy, 
inexpensive method of sterilizing needles must be found. Methods of 
isolation must be devised to minimize expenses while meeting the require-
ments for isolation. A number of such options should be available for each 
farmer. 
A second cost is the procurement of individual samples. For BLV, 
blood samples are considered necessary. It would be desirable to ascertain 
if milk samples could be used in place of blood samples. Also, a skilled 
technician for taking blood samples should be considerably less expensive 
than a veterinarian. It may not be advisable for a farmer to be the one to 
take blood samples after the first or second samplings. He would be 
suitable to take blood or milk samples if he was unable to determine 
whether or not a cow has BLV. If effects of the disease are not apparent 
to him, it is doubtful that he could bias the sample. Whoever takes the 
samples, precautions should be taken to prevent biases or possible biases 
in the samples submitted to the laboratory. Costs associated with storing 
and transmitting to the laboratory should also be minimized but not to the 
point of damaging the samples. 
Costs for reliable methods in the laboratory need to be minimized. 
The ELISA test (see Mammerickx ec aJ. (1984)) is a reliable test even for 
8.2 
dilutions up to one in 75. In addition to being sensitive, the test is 
relatively inexpensive (one dollar per sample). With such a test, group 
testing is feasible and can result in a considerable reduction, say 80-90%, 
of the number of samples processed. In computing savings, the cost 
associated with pooling samples needs to be ascertained and taken into 
account when considering the savings due to group testing. If these costs 
are appreciable, less inexpensive methods of pooling need to be studied. 
When such a test as the above ELISA is expensive compared to a second less 
sensitive and expensive test, the first sampling may utilize the second 
test on individual samples or on small pools, say less than five. Any 
animals missed in the first sampling will be picked up in later samplings. 
As the herd approaches the disease-free status, the more precise and 
expensive test would be put into use. 
Possibly the greatest reduction in costs can be achieved by lengthen-
ing the time interval between samplings. A procedure of sampling every 
month is three times more costly than sampling every three months. 
Sampling every six months is one-half as expensive as sampling at three-
month intervals. The longest interval that will achieve the desired goal 
should be used, but standards should not be lowered simply to minimize 
cost. The cheapest thing is to do nothing but this is ruled out. 
9.1 
9. DISSEMINATION OF INTERIM RESULTS 
In any cooperative program, it is necessary to inform the participants 
of the results as the surveillance program proceeds. Primarily farmers 
will be specifically interested in the progress they are making toward the 
disease-free status. This feedback should occur immediately after the 
samples are analyzed. At the same time, it should be pointed out how other 
control procedures would speed up or delay the approach to a BLV-free 
status. Secondarily, a farmer would be interested in the progress of other 
participants (as a group) toward BLV-free status. The information feedback 
is necessary to attain continued enthusiasm for the program. Also, any 
information on economic losses due to BLV should be disseminated. At 
present, it is thought that milk production is not affected by the BLV 
disease. This may not be a true statement but instead the effect may be 
small. For example, the disease may reduce production by two pounds per 
day, which is 730 pounds per year. If the cow is diseased for three years, 
this would be a loss of 2,190 pounds for the cow. Small differences in 
daily production can result in fairly sizable losses over the lifetime of a 
cow in the herd. Small losses would not be apparent to a dairyman. As 
information becomes available, it should be made known to dairy farmers. 
This could entice more farmers to join the program for milk production 
rather than for exporting reasons. 
The general dairy farm and animal production population should be kept 
informed of the progress of lowering prevalence of BLV in dairy herds in 
the study. 
10.1 
10. QUALITY CONTROL AND CHECKS 
In any sample analysis program, there should be constant monitoring of 
the various sample analyses being made and on the persons performing the 
analysis. Check samples of known composition should be randomly inter-
spersed in with the other samples. The identity of the check samples 
should be unknown to the analyst. It is suggested that check samples with 
one BLV sample and g-1 BLV-free samples and with two BLV samples and g-2 
BLV-free samples be included with a frequency of one to five percent for 
the population of herds; g is the group size used for the pools. Whenever 
a check sample is off by a designated amount, the entire lot would be rerun 
by another analyst to check on the method and the analyst. One rough rule 
for number of checks is to use ~N+1 checks when N samples are analyzed. 
This number could become rather large for very large N. Here it might be 
desired to use only one-tenth or one-half percent frequency for random 
checks. In performing a herd analysis, it may be desirable to include one 
or two checks for every sampling of a herd. In a group testing procedure, 
the check could be a single sample of a BLV cow with known titer or it 
could be a pool of g samples as described above. Perhaps various checks 
would be used for different herds and different samplings. A quality 
control procedure for group testing has not been developed to date. 
Charts on prevalence for each herd need to be prepared and updated as 
the surveillance continues. These would give the history of prevalence in 
a herd and the progress being made toward the goal of maintaining a 
BLV-free herd. Check sample results need to be included wherever they 
occur to validate the results. Perhaps copies of these graphs or charts 
should be sent to the owner of a herd as part of the information feedback 
discussed in Section 9. 
11.1 
11. PROGRAM EVALUATION 
The success of any proposed program depends on the cooperation of New 
York State dairymen. To obtain cooperation it may be necessary to assure 
confidentiality of lab tests for each herd. This can be done despite the 
state law open all New York State Diagnostic Laboratory record to the 
public. The results of laboratory analyses for each herd must be dissemi-
nated to the owner promptly. 
The proposed control program and laboratory procedures should be field 
tested prior to using them at the state level. 
12.1 
12. CONCLUSIONS AND SUMMARY 
It is concluded that the goal of a BLV-free herd can be achieved 
through good management practices. The cost of a surveillance and control 
program can be kept reasonable by minimizing costs at every stage. Group 
testing will be an effective procedure to reduce sample analysis costs and 
in preventing a backlog of samples to be analyzed. Timely information and 
feedback of information can be accomplished without being unduly costly. 
Group testing can be effectively used in a BLV surveillance and control 
program. Milk production records can be kept on BLV and BLV-free cows to 
assess the impact of the disease on production. Other related information 
can also be collected, processed, and given to dairymen. 
In the foregoing, a surveillance and control program has been out-
lined. Implementation of the plan in New York State will indicate aspects 
of the program requiring change. Various group testing and double sampling 
procedures have been described. Several methods for obtaining preliminary 
estimates of prevalence have been discussed. It is shown how and where 
costs of a surveillance and control program can be reduced. Constant 
checking is required to maintain the quality of the program. Some comments 
on this aspect are given but an unsolved statistical problem is to develop 
optimal quality control programs for group testing. Quality control checks 
will need to be instituted in every phase of the program. 
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